LT Foods Targets ~12% EBITDA as Tariff Normalizes

LT Foods Limited — Q4 FY26 Earnings Conference Call (Quarter & FY ended Mar 31, 2026) | May 15, 2026

1. Overall Tone of Management: Optimistic

• Management repeatedly emphasizes “strong execution,” “resilient growth,” “continued double-digit growth,” and “margins are expected to gradually improve.”
• Even when discussing stress (organic segment, currency/commodity pressure, tariff impacts), they frame it as remodeling/investment phase with a path to normalization (e.g., RTH capacity operational from Q2 FY27).

2. Key Themes from Management Commentary

• Strong top-line growth with brand-led strategy
• FY26 revenue (incl. other income) INR 11,023 crores, +26% YoY; basmati/specialty rice +29% revenue growth.
• Emphasis on premiumisation, innovation, and brand investments (marketing budget 2x vs last year in India).
• Margin pressure framed as investment + tariff normalization
• EBITDA margin 11.8% excluding U.S. tariff, with reported margins affected by U.S. tariff pass-through, UK investment phase, and organic remodeling.
• Management expects gross margins to normalize and EBITDA margins to improve toward ~12% as disruptions normalize.
• Working capital and balance sheet discipline
• Working capital days improved to 176 days vs 196 days.
• Net debt remains controlled: net debt/EBITDA 0.6x.
• Segment-specific execution
• Basmati & specialty rice: leadership in North America; strong India growth; premium SKU mix improving.
• Organic Foods & Ingredients: “under stress” due to currency fluctuations and commodity price pressure; management says they remodeled capacity and entered CPG business, but utilization will take time.
• RTH/RTC (ready-to-heat/ready-to-cook): grew 2.5x over 5 years; capacity constraints limited growth; enhanced capacities operational from Q2 FY27.
• Macro/geopolitical headwinds acknowledged
• Headwinds: geopolitical issues, U.S. tariff, increased freight, increased input costs.
• Middle East resilience: “no material disruption to our supply chain” despite conflict.

3. Q&A Analysis

Theme A: U.S. tariff impact, volumes, and margin mechanics

• Core questions
• U.S. and segment volume growth in FY26 and extent of tariff impact.
• How tariff affects gross margin/EBITDA and whether demand destruction is occurring.
• Management response
• Volume growth: basmati/specialty segment ~19% YoY; U.S. volume increased (with Golden Star) and service-level helped acquire customers; tariff impacted margin but not volumes materially.
• Tariff framing: tariff pass-through partially; service level maintained; margin impacted by timing/partial pass-through.
• Demand: “we have not seen any impact” on demand side (also “historically… food is the last thing to get impacted”).
• Notable / evasive / strong points
• Strong narrative: tariff disruption became an “opportunity” due to service level.
• Some accounting complexity acknowledged (tariff vs Golden Star consolidation; normalization methods), which can obscure clean causality.

Theme B: Guidance on margins (gross + EBITDA) for FY27

• Core questions
• Expected gross margin range and EBITDA margin trajectory for FY27.
• Whether margin improvement is realistic given tariff/input costs and UK/organic investments.
• Management response
• Gross margins: expected within range of FY25/FY26; tariff normalized from 50% to 10%, so gross margins should be similar to last year.
• Quantitative: gross margin range referenced around ~33%–33.5% (and FY25 ~24.6% mentioned as a comparison point).
• EBITDA margin: management says they are “eyeing ~12%” and confident to remain in the range of 12%.
• Notable / evasive / strong points
• Confidence is high (“we are confident”), but the explanation relies on normalization assumptions (tariff normalization, brand spend normalization).

Theme C: Capacity constraints and RTH/RTC ramp

• Core questions
• Why RTH/RTC growth is constrained; when capacity comes online.
• Internal targets, breakeven timing, and margin expectations for this segment.
• Management response
• Capacity constraint in RTH platform limited growth; enhanced capacities operational from Q2 FY27.
• Internal targets: RTH to reach ~30 million pouches / INR300 crores in next 2 years; RTC India ~INR100–120 crores by 2030.
• Breakeven: “achieving INR400 crores in the segment will make us breakeven”; management admits target moved due to capacity constraint but says otherwise on track.
• Notable / evasive / strong points
• Admission of delay: “our target has moved” due to capacity constraint—important credibility signal.

Theme D: Working capital / inventory / payable days

• Core questions
• Inventory aging (including >12 months / >2 years).
• Payable days rising (trade payables ~100 days) and whether it will normalize.
• Management response
• Inventory aging: average ~190–200 days; some premium products require 18 months to 2 years aging; management declined to quantify % beyond 2 years (asked to mail IR).
• Payables: 100 days will remain due to seasonal buying mix (60–70% in season; 30–40% off-season leads to deferred payments).
• Notable / evasive / strong points
• Partial non-answer on “% beyond two years” (asked to email IR).

Theme E: Capex plans and breakdown

• Core questions
• Capex breakup and FY27 capex outlook.
• Whether capex should be guided as % of sales.
• Management response
• FY26 capex: ~INR350 crores (and in one answer INR330-odd crores).
• Major capex: U.S. land purchase + RTH facility + Houston warehouse; U.K. packaging facility; India land/warehouses.
• FY27 capex: “similar range”; long-term trajectory suggests ~INR250 crores/year (also noting one-off buildup).
• Notable / evasive / strong points
• Capex guidance is somewhat inconsistent in magnitude (330-odd vs 350 vs 250 “long-term trajectory”), though explained as one-offs.

Theme F: Golden Star contribution and margins

• Core questions
• Golden Star revenue contribution and margin profile.
• Q4 revenue run-rate.
• Management response
• Golden Star: ~10% of overall revenue in this segment; EBITDA margins not separately tracked due to consolidation.
• Q4 Golden Star revenue: ~INR250 crores (proportionately divided).
• Notable / evasive / strong points
• Margin transparency limited because it’s merged into consolidated reporting.

4. Guidance / Outlook

Explicit guidance (quantitative)

• Growth
• “For the future, we expect continued double-digit growth.”
• Long-term growth target: “10% to 12% of growth on a long-term basis.”
• Margins
• Gross margin: expected within FY25/FY26 range; tariff normalized from 50% to 10%.
• EBITDA margin: management says they are “eyeing that level” and “confident… in the range of 12%.”
• RTH/RTC
• RTH capacity operational: from Q2 FY27.
• RTH internal target: ~30 million pouches / INR300 crores in next 2 years.
• Breakeven: ~INR400 crores segment revenue (target moved due to capacity constraint).
• Capex
• FY27 capex: “similar range” to FY26.
• Long-term conservative capex: ~INR250 crores/year (with caveat that recent years include capacity build).
• Inventory / working capital
• No explicit numeric guidance, but working capital days improved and net debt controlled.

Implicit signals (qualitative)

• Brand investment normalization is expected to support margin recovery (“as brand investments normalize, scale benefits come through”).
• Organic segment remains a near-term drag (“under stress… remodeled… capacity will take time to get fully utilized”).
• Demand resilience: management repeatedly claims no demand destruction despite tariffs and inflation.

5. Standout Statements (direct / revealing)

• On growth + transformation
• “FY26 has been a year of strong execution, resilient growth and continued transformation into a global branded FMCG company.”
• On margin recovery
• “Margins are expected to gradually improve as brand investments normalize, scale benefits come through.”
• “We are confident that we will be in the range of 12%.”
• On organic stress
• “However, this business segment is under stress… we have strategically remodeled it for the next phase of the growth… capacity… will take time to get fully utilized.”
• “EBITDA is also currently under stress due to currency fluctuations and commodity price pressure.”
• On RTH capacity delay
• “certain growth opportunities could not be fully serviced due to capacity constraints… expected to become operational from Q2 FY’27.”
• “our target has moved” (breakeven timing) due to capacity constraint.
• On tariff as opportunity
• “So this was an opportunity for us… with a better service level… we have been able to acquire more consumer… although it has impacted on our margin”
• On payable days
• “So the payable days of 100 days… will remain as such.”

6. Red Flags / Positive Signals

Red flags
– Margin guidance depends on normalization (tariff normalization, brand spend normalization, “dynamic environment”).
– Organic segment explicitly described as under stress with EBITDA under stress—risk to medium-term margin trajectory.
– Capacity constraint admitted with breakeven target movement for RTH/RTC.
– Some transparency gaps:
– Inventory aging beyond 2 years: management asked to mail IR.
– Golden Star margins not separately tracked due to consolidation.

Positive signals
– Working capital improvement (176 days vs 196 days) and controlled net debt (0.6x net debt/EBITDA).
– Demand resilience claims are consistent across calls (tariff/inflation not causing demand destruction).
– Clear operational milestones (RTH capacity operational from Q2 FY27; capex breakdown provided).

7. Historical Comparison & Consistency Analysis (vs prior calls)

a. Change in Tone Over Time

• Current (Q4 FY26): More Optimistic
• Stronger forward-looking confidence: “committed to continued double-digit growth,” “confident… range of 12%.”
• Prior calls (Q3 FY26 / Q2 FY26 / Q1 FY26): More cautious on margin
• Earlier, margin compression was attributed to tariff disruption, brand investments, organic margin pressures, and management often said normalization would take time.
• What changed
• Management now frames tariff impact as more normalized (“tariff normalized from 50% to 10%”) and points to specific capacity coming online (Q2 FY27)—reducing uncertainty vs earlier “watch next quarter” language.

b. Tracking Past Commitments vs Outcomes

• RTH/RTC breakeven timing
• Prior (Q2 FY26 / Q3 FY26): breakeven expected once segment crosses ~INR350–400 crores, with delays tied to capacity.
• Current: still targets breakeven at INR400 crores, but explicitly says “target has moved” due to capacity constraint; capacity now expected Q2 FY27.
• Flag: ⏳ Delayed (breakeven timing pushed; capacity constraint acknowledged again).
• Tariff pass-through / margin normalization
• Prior: management said tariff was being passed on “in phases” and margins would be clearer later.
• Current: claims tariff normalized and expects gross margins within range and EBITDA ~12%.
• Flag: ✅/⏳ Partially delivered (growth strong; margins still pressured by investments/organic/UK, but guidance confidence improved).
• Organic segment “rebound”
• Prior (Q3 FY26): organic expected to rebound by end of year; margin settlement expected after one more quarter.
• Current: organic still described as under stress with remodeling and capacity utilization taking time.
• Flag: ❌/⏳ Not fully delivered (narrative suggests ongoing underperformance rather than full rebound).

c. Narrative Shifts

• Organic segment emphasis increased as a drag
• Earlier calls discussed organic growth and some margin pressure; now management explicitly says “under stress” and details remodeling + CPG entry.
• RTH/RTC moved from “capacity ramp” to “capacity constraint limiting growth”
• Current call repeats constraint and gives a concrete operational date (Q2 FY27).
• Tariff narrative shifts from “uncertainty” to “normalization”
• Earlier: “watch next two months / next quarter.”
• Now: “tariff normalized from 50% to 10%” and margin range guidance.

d. Consistency & Credibility Signals

• Medium credibility
• Strengths: management provides operational milestones and quantitative ranges (EBITDA ~12%, capex range, RTH capacity timing).
• Weaknesses: repeated “normalization” language while organic and RTH delays persist, and some numeric guidance varies (capex figures; gross margin comparisons depend on normalization adjustments).

e. Evolution of Key Themes

• Demand / premiumisation: Improving / Stable
• Premiumisation and premium SKU mix continue to be highlighted.
• Margins: Stable-to-improving expectation, but with ongoing segment-specific drag
• Gross margin expected stable; EBITDA expected to return to ~12%.
• Expansion / capacity: Improving but delayed execution
• RTH capacity now tied to Q2 FY27; UK investment phase continues to affect margins.
• Geopolitical risk: Persistent but managed
• Middle East resilience reiterated; freight disruptions acknowledged.

f. Additional Insights (cross-period intelligence)

• A risk that was previously “temporary” (margin pressure from disruptions) now appears structural in pockets:
• Organic segment remains under stress despite prior expectations of rebound.
• Management’s confidence has increased, but the call still contains multiple “timing” dependencies (tariff normalization, brand investment normalization, RTH capacity ramp, organic capacity utilization), which can mask execution risk.